https://wikifarmaco.org/index.php?action=history&feed=atom&title=Repaglinide 2026-06-23T11:52:22Z Cronologia della pagina su questo sito MediaWiki 1.30.2 https://wikifarmaco.org/index.php?title=Repaglinide&diff=56359&oldid=prev 2024-04-12T15:29:46Z

<p></p> <table class="diff diff-contentalign-left" data-mw="interface"> <col class="diff-marker" /> <col class="diff-content" /> <col class="diff-marker" /> <col class="diff-content" /> <tr style="vertical-align: top;" lang="it"> <td colspan="2" style="background-color: white; color:black; text-align: center;">← Versione meno recente</td> <td colspan="2" style="background-color: white; color:black; text-align: center;">Versione delle 15:29, 12 apr 2024</td> </tr><tr><td colspan="2" class="diff-lineno" id="mw-diff-left-l5" >Riga 5:</td> <td colspan="2" class="diff-lineno">Riga 5:</td></tr> <tr><td class='diff-marker'>&#160;</td><td style="background-color: #f9f9f9; color: #333333; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #e6e6e6; vertical-align: top; white-space: pre-wrap;"><div>|description= &#160;</div></td><td class='diff-marker'>&#160;</td><td style="background-color: #f9f9f9; color: #333333; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #e6e6e6; vertical-align: top; white-space: pre-wrap;"><div>|description= &#160;</div></td></tr> <tr><td class='diff-marker'>&#160;</td><td style="background-color: #f9f9f9; color: #333333; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #e6e6e6; vertical-align: top; white-space: pre-wrap;"><div>}}</div></td><td class='diff-marker'>&#160;</td><td style="background-color: #f9f9f9; color: #333333; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #e6e6e6; vertical-align: top; white-space: pre-wrap;"><div>}}</div></td></tr> <tr><td colspan="2">&#160;</td><td class='diff-marker'>+</td><td style="color:black; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div><ins style="font-weight: bold; text-decoration: none;">{{categorytreeall|Ipoglicemizzanti|mode=all|onlyroot= |depth=}}</ins></div></td></tr> <tr><td class='diff-marker'>&#160;</td><td style="background-color: #f9f9f9; color: #333333; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #e6e6e6; vertical-align: top; white-space: pre-wrap;"><div>== SPECIALITÀ ==</div></td><td class='diff-marker'>&#160;</td><td style="background-color: #f9f9f9; color: #333333; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #e6e6e6; vertical-align: top; white-space: pre-wrap;"><div>== SPECIALITÀ ==</div></td></tr> <tr><td class='diff-marker'>&#160;</td><td style="background-color: #f9f9f9; color: #333333; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #e6e6e6; vertical-align: top; white-space: pre-wrap;"><div>*'''[[Enyglid]]''' 90CPR 0,5MG, 90CPR 1MG, 90CPR 2MG [http://www.ema.europa.eu/docs/it_IT/document_library/EPAR_-_Summary_for_the_public/human/001065/WC500055950.pdf''Riassunto EMA'']</div></td><td class='diff-marker'>&#160;</td><td style="background-color: #f9f9f9; color: #333333; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #e6e6e6; vertical-align: top; white-space: pre-wrap;"><div>*'''[[Enyglid]]''' 90CPR 0,5MG, 90CPR 1MG, 90CPR 2MG [http://www.ema.europa.eu/docs/it_IT/document_library/EPAR_-_Summary_for_the_public/human/001065/WC500055950.pdf''Riassunto EMA'']</div></td></tr> <!-- diff cache key wikifarmaco_db_5-mw_:diff:version:1.11a:oldid:51707:newid:56359 --> </table>

Hadihajar https://wikifarmaco.org/index.php?title=Repaglinide&diff=51707&oldid=prev 2014-08-26T20:11:06Z

<p>Sostituzione testo - &#039;|titlemode= append&#039; con &#039;|titlemode=&#039;</p> <table class="diff diff-contentalign-left" data-mw="interface"> <col class="diff-marker" /> <col class="diff-content" /> <col class="diff-marker" /> <col class="diff-content" /> <tr style="vertical-align: top;" lang="it"> <td colspan="2" style="background-color: white; color:black; text-align: center;">← Versione meno recente</td> <td colspan="2" style="background-color: white; color:black; text-align: center;">Versione delle 20:11, 26 ago 2014</td> </tr><tr><td colspan="2" class="diff-lineno" id="mw-diff-left-l1" >Riga 1:</td> <td colspan="2" class="diff-lineno">Riga 1:</td></tr> <tr><td class='diff-marker'>&#160;</td><td style="background-color: #f9f9f9; color: #333333; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #e6e6e6; vertical-align: top; white-space: pre-wrap;"><div>{{Avvertenze}}{{#seo:</div></td><td class='diff-marker'>&#160;</td><td style="background-color: #f9f9f9; color: #333333; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #e6e6e6; vertical-align: top; white-space: pre-wrap;"><div>{{Avvertenze}}{{#seo:</div></td></tr> <tr><td class='diff-marker'>&#160;</td><td style="background-color: #f9f9f9; color: #333333; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #e6e6e6; vertical-align: top; white-space: pre-wrap;"><div>|title= &#160;</div></td><td class='diff-marker'>&#160;</td><td style="background-color: #f9f9f9; color: #333333; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #e6e6e6; vertical-align: top; white-space: pre-wrap;"><div>|title= &#160;</div></td></tr> <tr><td class='diff-marker'>−</td><td style="color:black; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;"><div>|titlemode= <del class="diffchange diffchange-inline">append</del></div></td><td class='diff-marker'>+</td><td style="color:black; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div>|titlemode=</div></td></tr> <tr><td class='diff-marker'>&#160;</td><td style="background-color: #f9f9f9; color: #333333; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #e6e6e6; vertical-align: top; white-space: pre-wrap;"><div>|keywords= &#160;</div></td><td class='diff-marker'>&#160;</td><td style="background-color: #f9f9f9; color: #333333; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #e6e6e6; vertical-align: top; white-space: pre-wrap;"><div>|keywords= &#160;</div></td></tr> <tr><td class='diff-marker'>&#160;</td><td style="background-color: #f9f9f9; color: #333333; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #e6e6e6; vertical-align: top; white-space: pre-wrap;"><div>|description= &#160;</div></td><td class='diff-marker'>&#160;</td><td style="background-color: #f9f9f9; color: #333333; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #e6e6e6; vertical-align: top; white-space: pre-wrap;"><div>|description= &#160;</div></td></tr> <!-- diff cache key wikifarmaco_db_5-mw_:diff:version:1.11a:oldid:46886:newid:51707 --> </table>

Hadihajar https://wikifarmaco.org/index.php?title=Repaglinide&diff=46886&oldid=prev 2014-04-06T05:18:06Z

<p></p> <table class="diff diff-contentalign-left" data-mw="interface"> <col class="diff-marker" /> <col class="diff-content" /> <col class="diff-marker" /> <col class="diff-content" /> <tr style="vertical-align: top;" lang="it"> <td colspan="2" style="background-color: white; color:black; text-align: center;">← Versione meno recente</td> <td colspan="2" style="background-color: white; color:black; text-align: center;">Versione delle 05:18, 6 apr 2014</td> </tr><tr><td colspan="2" class="diff-lineno" id="mw-diff-left-l5" >Riga 5:</td> <td colspan="2" class="diff-lineno">Riga 5:</td></tr> <tr><td class='diff-marker'>&#160;</td><td style="background-color: #f9f9f9; color: #333333; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #e6e6e6; vertical-align: top; white-space: pre-wrap;"><div>|description= &#160;</div></td><td class='diff-marker'>&#160;</td><td style="background-color: #f9f9f9; color: #333333; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #e6e6e6; vertical-align: top; white-space: pre-wrap;"><div>|description= &#160;</div></td></tr> <tr><td class='diff-marker'>&#160;</td><td style="background-color: #f9f9f9; color: #333333; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #e6e6e6; vertical-align: top; white-space: pre-wrap;"><div>}}</div></td><td class='diff-marker'>&#160;</td><td style="background-color: #f9f9f9; color: #333333; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #e6e6e6; vertical-align: top; white-space: pre-wrap;"><div>}}</div></td></tr> <tr><td class='diff-marker'>−</td><td style="color:black; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;"><div><del style="font-weight: bold; text-decoration: none;">{{categorytreeall|Ipoglicemizzanti|mode=all|onlyroot= |depth=}}</del></div></td><td colspan="2">&#160;</td></tr> <tr><td class='diff-marker'>&#160;</td><td style="background-color: #f9f9f9; color: #333333; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #e6e6e6; vertical-align: top; white-space: pre-wrap;"><div>== SPECIALITÀ ==</div></td><td class='diff-marker'>&#160;</td><td style="background-color: #f9f9f9; color: #333333; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #e6e6e6; vertical-align: top; white-space: pre-wrap;"><div>== SPECIALITÀ ==</div></td></tr> <tr><td class='diff-marker'>&#160;</td><td style="background-color: #f9f9f9; color: #333333; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #e6e6e6; vertical-align: top; white-space: pre-wrap;"><div>*'''[[Enyglid]]''' 90CPR 0,5MG, 90CPR 1MG, 90CPR 2MG [http://www.ema.europa.eu/docs/it_IT/document_library/EPAR_-_Summary_for_the_public/human/001065/WC500055950.pdf''Riassunto EMA'']</div></td><td class='diff-marker'>&#160;</td><td style="background-color: #f9f9f9; color: #333333; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #e6e6e6; vertical-align: top; white-space: pre-wrap;"><div>*'''[[Enyglid]]''' 90CPR 0,5MG, 90CPR 1MG, 90CPR 2MG [http://www.ema.europa.eu/docs/it_IT/document_library/EPAR_-_Summary_for_the_public/human/001065/WC500055950.pdf''Riassunto EMA'']</div></td></tr> <tr><td colspan="2" class="diff-lineno" id="mw-diff-left-l56" >Riga 56:</td> <td colspan="2" class="diff-lineno">Riga 55:</td></tr> <tr><td class='diff-marker'>&#160;</td><td style="background-color: #f9f9f9; color: #333333; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #e6e6e6; vertical-align: top; white-space: pre-wrap;"><div>[[Categoria:Principi attivi]] &#160;</div></td><td class='diff-marker'>&#160;</td><td style="background-color: #f9f9f9; color: #333333; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #e6e6e6; vertical-align: top; white-space: pre-wrap;"><div>[[Categoria:Principi attivi]] &#160;</div></td></tr> <tr><td class='diff-marker'>&#160;</td><td style="background-color: #f9f9f9; color: #333333; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #e6e6e6; vertical-align: top; white-space: pre-wrap;"><div>[[Categoria:Ipoglicemizzanti]]</div></td><td class='diff-marker'>&#160;</td><td style="background-color: #f9f9f9; color: #333333; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #e6e6e6; vertical-align: top; white-space: pre-wrap;"><div>[[Categoria:Ipoglicemizzanti]]</div></td></tr> <tr><td colspan="2">&#160;</td><td class='diff-marker'>+</td><td style="color:black; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div><ins style="font-weight: bold; text-decoration: none;">{{Diabete}}</ins></div></td></tr> <!-- diff cache key wikifarmaco_db_5-mw_:diff:version:1.11a:oldid:45597:newid:46886 --> </table>

Hadihajar https://wikifarmaco.org/index.php?title=Repaglinide&diff=45597&oldid=prev 2014-03-21T13:47:53Z

<p>Sostituzione testo - &#039;{{Avvertenze}} {{#seo:&#039; con &#039;{{Avvertenze}}{{#seo:&#039;</p> <table class="diff diff-contentalign-left" data-mw="interface"> <col class="diff-marker" /> <col class="diff-content" /> <col class="diff-marker" /> <col class="diff-content" /> <tr style="vertical-align: top;" lang="it"> <td colspan="2" style="background-color: white; color:black; text-align: center;">← Versione meno recente</td> <td colspan="2" style="background-color: white; color:black; text-align: center;">Versione delle 13:47, 21 mar 2014</td> </tr><tr><td colspan="2" class="diff-lineno" id="mw-diff-left-l1" >Riga 1:</td> <td colspan="2" class="diff-lineno">Riga 1:</td></tr> <tr><td class='diff-marker'>−</td><td style="color:black; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;"><div>{{Avvertenze}}</div></td><td class='diff-marker'>+</td><td style="color:black; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div>{{Avvertenze}}{{#seo:</div></td></tr> <tr><td class='diff-marker'>−</td><td style="color:black; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;"><div>{{#seo:</div></td><td colspan="2">&#160;</td></tr> <tr><td class='diff-marker'>&#160;</td><td style="background-color: #f9f9f9; color: #333333; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #e6e6e6; vertical-align: top; white-space: pre-wrap;"><div>|title= &#160;</div></td><td class='diff-marker'>&#160;</td><td style="background-color: #f9f9f9; color: #333333; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #e6e6e6; vertical-align: top; white-space: pre-wrap;"><div>|title= &#160;</div></td></tr> <tr><td class='diff-marker'>&#160;</td><td style="background-color: #f9f9f9; color: #333333; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #e6e6e6; vertical-align: top; white-space: pre-wrap;"><div>|titlemode= append</div></td><td class='diff-marker'>&#160;</td><td style="background-color: #f9f9f9; color: #333333; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #e6e6e6; vertical-align: top; white-space: pre-wrap;"><div>|titlemode= append</div></td></tr> <!-- diff cache key wikifarmaco_db_5-mw_:diff:version:1.11a:oldid:38727:newid:45597 --> </table>

Hadihajar https://wikifarmaco.org/index.php?title=Repaglinide&diff=38727&oldid=prev 2013-12-19T13:55:52Z

<p>‎<span dir="auto"><span class="autocomment">SPECIALITÀ</span></span></p> <table class="diff diff-contentalign-left" data-mw="interface"> <col class="diff-marker" /> <col class="diff-content" /> <col class="diff-marker" /> <col class="diff-content" /> <tr style="vertical-align: top;" lang="it"> <td colspan="2" style="background-color: white; color:black; text-align: center;">← Versione meno recente</td> <td colspan="2" style="background-color: white; color:black; text-align: center;">Versione delle 13:55, 19 dic 2013</td> </tr><tr><td colspan="2" class="diff-lineno" id="mw-diff-left-l9" >Riga 9:</td> <td colspan="2" class="diff-lineno">Riga 9:</td></tr> <tr><td class='diff-marker'>&#160;</td><td style="background-color: #f9f9f9; color: #333333; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #e6e6e6; vertical-align: top; white-space: pre-wrap;"><div>== SPECIALITÀ ==</div></td><td class='diff-marker'>&#160;</td><td style="background-color: #f9f9f9; color: #333333; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #e6e6e6; vertical-align: top; white-space: pre-wrap;"><div>== SPECIALITÀ ==</div></td></tr> <tr><td class='diff-marker'>&#160;</td><td style="background-color: #f9f9f9; color: #333333; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #e6e6e6; vertical-align: top; white-space: pre-wrap;"><div>*'''[[Enyglid]]''' 90CPR 0,5MG, 90CPR 1MG, 90CPR 2MG [http://www.ema.europa.eu/docs/it_IT/document_library/EPAR_-_Summary_for_the_public/human/001065/WC500055950.pdf''Riassunto EMA'']</div></td><td class='diff-marker'>&#160;</td><td style="background-color: #f9f9f9; color: #333333; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #e6e6e6; vertical-align: top; white-space: pre-wrap;"><div>*'''[[Enyglid]]''' 90CPR 0,5MG, 90CPR 1MG, 90CPR 2MG [http://www.ema.europa.eu/docs/it_IT/document_library/EPAR_-_Summary_for_the_public/human/001065/WC500055950.pdf''Riassunto EMA'']</div></td></tr> <tr><td class='diff-marker'>−</td><td style="color:black; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;"><div>*'''[[Novonorm]]''' <del class="diffchange diffchange-inline">90CPR 0,5MG, 90CPR 1MG, 90CPR 2MG </del>[http://www.ema.europa.eu/docs/it_IT/document_library/EPAR_-_Summary_for_the_public/human/000187/WC500029903.pdf''Riassunto EMA''] , [http://www.dottnet.it/TFI/Allegati.aspx?file=2007-07-005270-Novonorm%200,5mg.pdf''monografia'']</div></td><td class='diff-marker'>+</td><td style="color:black; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div>*'''[[Novonorm]]''' [http://www.ema.europa.eu/docs/it_IT/document_library/EPAR_-_Summary_for_the_public/human/000187/WC500029903.pdf''Riassunto EMA'']</div></td></tr> <tr><td class='diff-marker'>−</td><td style="color:black; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;"><div>*'''[[Repaglinide <del class="diffchange diffchange-inline">generico]]</del>''' [http://www.ema.europa.eu/docs/it_IT/document_library/EPAR_-_Summary_for_the_public/human/001067/WC500053313.pdf''Riassunto EMA''] <del class="diffchange diffchange-inline">90CPR 0,5MG, 90CPR 1MG, 90CPR 2MG</del></div></td><td class='diff-marker'>+</td><td style="color:black; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div><ins class="diffchange diffchange-inline">**90CPR 0</ins>,<ins class="diffchange diffchange-inline">5MG </ins>[http://www.dottnet.it/TFI/Allegati.aspx?file=2007-07-005270-Novonorm%200,5mg.pdf''monografia'']</div></td></tr> <tr><td colspan="2">&#160;</td><td class='diff-marker'>+</td><td style="color:black; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div>*<ins class="diffchange diffchange-inline">*90CPR 1MG [http://www.dottnet.it/TFI/Allegati.aspx?file=2007-07-005271-Novonorm+1mg.pdf'</ins>'<ins class="diffchange diffchange-inline">monografia</ins>''<ins class="diffchange diffchange-inline">]</ins></div></td></tr> <tr><td colspan="2">&#160;</td><td class='diff-marker'>+</td><td style="color:black; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div><ins class="diffchange diffchange-inline">**90CPR 2MG&#160; </ins>[<ins class="diffchange diffchange-inline">http://www.dottnet.it/TFI/Allegati.aspx?file=2007-07-005272-Novonorm+2mg.pdf''monografia'']</ins></div></td></tr> <tr><td colspan="2">&#160;</td><td class='diff-marker'>+</td><td style="color:black; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div><ins class="diffchange diffchange-inline">*'''Repaglinide generico'''&#160; 90CPR 0,5MG, 90CPR 1MG, 90CPR 2MG </ins>[<ins class="diffchange diffchange-inline">http://www.dottnet.it/TFI/Allegati.aspx?file=2010-05-008310-</ins>Repaglinide<ins class="diffchange diffchange-inline">+EG.pdf</ins>''<ins class="diffchange diffchange-inline">monografia</ins>'<ins class="diffchange diffchange-inline">'], </ins>[http://www.ema.europa.eu/docs/it_IT/document_library/EPAR_-_Summary_for_the_public/human/001067/WC500053313.pdf''Riassunto EMA'']</div></td></tr> <tr><td class='diff-marker'>&#160;</td><td style="background-color: #f9f9f9; color: #333333; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #e6e6e6; vertical-align: top; white-space: pre-wrap;"></td><td class='diff-marker'>&#160;</td><td style="background-color: #f9f9f9; color: #333333; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #e6e6e6; vertical-align: top; white-space: pre-wrap;"></td></tr> <tr><td class='diff-marker'>&#160;</td><td style="background-color: #f9f9f9; color: #333333; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #e6e6e6; vertical-align: top; white-space: pre-wrap;"><div>== STRUTTURA ==</div></td><td class='diff-marker'>&#160;</td><td style="background-color: #f9f9f9; color: #333333; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #e6e6e6; vertical-align: top; white-space: pre-wrap;"><div>== STRUTTURA ==</div></td></tr> <!-- diff cache key wikifarmaco_db_5-mw_:diff:version:1.11a:oldid:35763:newid:38727 --> </table>

Hadihajar https://wikifarmaco.org/index.php?title=Repaglinide&diff=35763&oldid=prev 2013-11-15T23:56:21Z

<p></p> <table class="diff diff-contentalign-left" data-mw="interface"> <col class="diff-marker" /> <col class="diff-content" /> <col class="diff-marker" /> <col class="diff-content" /> <tr style="vertical-align: top;" lang="it"> <td colspan="2" style="background-color: white; color:black; text-align: center;">← Versione meno recente</td> <td colspan="2" style="background-color: white; color:black; text-align: center;">Versione delle 23:56, 15 nov 2013</td> </tr><tr><td colspan="2" class="diff-lineno" id="mw-diff-left-l1" >Riga 1:</td> <td colspan="2" class="diff-lineno">Riga 1:</td></tr> <tr><td colspan="2">&#160;</td><td class='diff-marker'>+</td><td style="color:black; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div><ins style="font-weight: bold; text-decoration: none;">{{Avvertenze}}</ins></div></td></tr> <tr><td colspan="2">&#160;</td><td class='diff-marker'>+</td><td style="color:black; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div><ins style="font-weight: bold; text-decoration: none;">{{#seo:</ins></div></td></tr> <tr><td colspan="2">&#160;</td><td class='diff-marker'>+</td><td style="color:black; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div><ins style="font-weight: bold; text-decoration: none;">|title= </ins></div></td></tr> <tr><td colspan="2">&#160;</td><td class='diff-marker'>+</td><td style="color:black; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div><ins style="font-weight: bold; text-decoration: none;">|titlemode= append</ins></div></td></tr> <tr><td colspan="2">&#160;</td><td class='diff-marker'>+</td><td style="color:black; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div><ins style="font-weight: bold; text-decoration: none;">|keywords= </ins></div></td></tr> <tr><td colspan="2">&#160;</td><td class='diff-marker'>+</td><td style="color:black; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div><ins style="font-weight: bold; text-decoration: none;">|description= </ins></div></td></tr> <tr><td colspan="2">&#160;</td><td class='diff-marker'>+</td><td style="color:black; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div><ins style="font-weight: bold; text-decoration: none;">}}</ins></div></td></tr> <tr><td class='diff-marker'>&#160;</td><td style="background-color: #f9f9f9; color: #333333; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #e6e6e6; vertical-align: top; white-space: pre-wrap;"><div>{{categorytreeall|Ipoglicemizzanti|mode=all|onlyroot= |depth=}}</div></td><td class='diff-marker'>&#160;</td><td style="background-color: #f9f9f9; color: #333333; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #e6e6e6; vertical-align: top; white-space: pre-wrap;"><div>{{categorytreeall|Ipoglicemizzanti|mode=all|onlyroot= |depth=}}</div></td></tr> <tr><td class='diff-marker'>&#160;</td><td style="background-color: #f9f9f9; color: #333333; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #e6e6e6; vertical-align: top; white-space: pre-wrap;"><div>== SPECIALITÀ ==</div></td><td class='diff-marker'>&#160;</td><td style="background-color: #f9f9f9; color: #333333; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #e6e6e6; vertical-align: top; white-space: pre-wrap;"><div>== SPECIALITÀ ==</div></td></tr> </table>

Hadihajar https://wikifarmaco.org/index.php?title=Repaglinide&diff=32006&oldid=prev 2013-07-05T21:32:31Z

<p>‎<span dir="auto"><span class="autocomment">SPECIALITÀ</span></span></p> <table class="diff diff-contentalign-left" data-mw="interface"> <col class="diff-marker" /> <col class="diff-content" /> <col class="diff-marker" /> <col class="diff-content" /> <tr style="vertical-align: top;" lang="it"> <td colspan="2" style="background-color: white; color:black; text-align: center;">← Versione meno recente</td> <td colspan="2" style="background-color: white; color:black; text-align: center;">Versione delle 21:32, 5 lug 2013</td> </tr><tr><td colspan="2" class="diff-lineno" id="mw-diff-left-l1" >Riga 1:</td> <td colspan="2" class="diff-lineno">Riga 1:</td></tr> <tr><td class='diff-marker'>&#160;</td><td style="background-color: #f9f9f9; color: #333333; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #e6e6e6; vertical-align: top; white-space: pre-wrap;"><div>{{categorytreeall|Ipoglicemizzanti|mode=all|onlyroot= |depth=}}</div></td><td class='diff-marker'>&#160;</td><td style="background-color: #f9f9f9; color: #333333; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #e6e6e6; vertical-align: top; white-space: pre-wrap;"><div>{{categorytreeall|Ipoglicemizzanti|mode=all|onlyroot= |depth=}}</div></td></tr> <tr><td class='diff-marker'>&#160;</td><td style="background-color: #f9f9f9; color: #333333; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #e6e6e6; vertical-align: top; white-space: pre-wrap;"><div>== SPECIALITÀ ==</div></td><td class='diff-marker'>&#160;</td><td style="background-color: #f9f9f9; color: #333333; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #e6e6e6; vertical-align: top; white-space: pre-wrap;"><div>== SPECIALITÀ ==</div></td></tr> <tr><td colspan="2">&#160;</td><td class='diff-marker'>+</td><td style="color:black; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div><ins style="font-weight: bold; text-decoration: none;">*'''[[Enyglid]]''' 90CPR 0,5MG, 90CPR 1MG, 90CPR 2MG [http://www.ema.europa.eu/docs/it_IT/document_library/EPAR_-_Summary_for_the_public/human/001065/WC500055950.pdf''Riassunto EMA'']</ins></div></td></tr> <tr><td class='diff-marker'>&#160;</td><td style="background-color: #f9f9f9; color: #333333; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #e6e6e6; vertical-align: top; white-space: pre-wrap;"><div>*'''[[Novonorm]]''' 90CPR 0,5MG, 90CPR 1MG, 90CPR 2MG [http://www.ema.europa.eu/docs/it_IT/document_library/EPAR_-_Summary_for_the_public/human/000187/WC500029903.pdf''Riassunto EMA''] , [http://www.dottnet.it/TFI/Allegati.aspx?file=2007-07-005270-Novonorm%200,5mg.pdf''monografia'']</div></td><td class='diff-marker'>&#160;</td><td style="background-color: #f9f9f9; color: #333333; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #e6e6e6; vertical-align: top; white-space: pre-wrap;"><div>*'''[[Novonorm]]''' 90CPR 0,5MG, 90CPR 1MG, 90CPR 2MG [http://www.ema.europa.eu/docs/it_IT/document_library/EPAR_-_Summary_for_the_public/human/000187/WC500029903.pdf''Riassunto EMA''] , [http://www.dottnet.it/TFI/Allegati.aspx?file=2007-07-005270-Novonorm%200,5mg.pdf''monografia'']</div></td></tr> <tr><td class='diff-marker'>&#160;</td><td style="background-color: #f9f9f9; color: #333333; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #e6e6e6; vertical-align: top; white-space: pre-wrap;"><div>*'''[[Repaglinide generico]]''' [http://www.ema.europa.eu/docs/it_IT/document_library/EPAR_-_Summary_for_the_public/human/001067/WC500053313.pdf''Riassunto EMA''] 90CPR 0,5MG, 90CPR 1MG, 90CPR 2MG</div></td><td class='diff-marker'>&#160;</td><td style="background-color: #f9f9f9; color: #333333; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #e6e6e6; vertical-align: top; white-space: pre-wrap;"><div>*'''[[Repaglinide generico]]''' [http://www.ema.europa.eu/docs/it_IT/document_library/EPAR_-_Summary_for_the_public/human/001067/WC500053313.pdf''Riassunto EMA''] 90CPR 0,5MG, 90CPR 1MG, 90CPR 2MG</div></td></tr> </table>

Hadihajar https://wikifarmaco.org/index.php?title=Repaglinide&diff=30551&oldid=prev 2013-04-26T22:37:21Z

<p></p> <table class="diff diff-contentalign-left" data-mw="interface"> <col class="diff-marker" /> <col class="diff-content" /> <col class="diff-marker" /> <col class="diff-content" /> <tr style="vertical-align: top;" lang="it"> <td colspan="2" style="background-color: white; color:black; text-align: center;">← Versione meno recente</td> <td colspan="2" style="background-color: white; color:black; text-align: center;">Versione delle 22:37, 26 apr 2013</td> </tr><tr><td colspan="2" class="diff-lineno" id="mw-diff-left-l1" >Riga 1:</td> <td colspan="2" class="diff-lineno">Riga 1:</td></tr> <tr><td class='diff-marker'>−</td><td style="color:black; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;"><div><del class="diffchange diffchange-inline">&lt;categorytree </del>mode=all <del class="diffchange diffchange-inline">style</del>=<del class="diffchange diffchange-inline">&quot;float:right; clear:right; margin-left:1ex; border:1px solid gray; padding:0.7ex; background-color:skyblue;&quot;&gt;Ipoglicemizzanti&lt;/categorytree&gt;</del></div></td><td class='diff-marker'>+</td><td style="color:black; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div><ins class="diffchange diffchange-inline">{{categorytreeall|Ipoglicemizzanti|</ins>mode=all<ins class="diffchange diffchange-inline">|onlyroot</ins>= <ins class="diffchange diffchange-inline">|depth=}}</ins></div></td></tr> <tr><td class='diff-marker'>&#160;</td><td style="background-color: #f9f9f9; color: #333333; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #e6e6e6; vertical-align: top; white-space: pre-wrap;"><div>== SPECIALITÀ ==</div></td><td class='diff-marker'>&#160;</td><td style="background-color: #f9f9f9; color: #333333; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #e6e6e6; vertical-align: top; white-space: pre-wrap;"><div>== SPECIALITÀ ==</div></td></tr> <tr><td class='diff-marker'>&#160;</td><td style="background-color: #f9f9f9; color: #333333; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #e6e6e6; vertical-align: top; white-space: pre-wrap;"><div>*'''[[Novonorm]]''' 90CPR 0,5MG, 90CPR 1MG, 90CPR 2MG [http://www.ema.europa.eu/docs/it_IT/document_library/EPAR_-_Summary_for_the_public/human/000187/WC500029903.pdf''Riassunto EMA''] , [http://www.dottnet.it/TFI/Allegati.aspx?file=2007-07-005270-Novonorm%200,5mg.pdf''monografia'']</div></td><td class='diff-marker'>&#160;</td><td style="background-color: #f9f9f9; color: #333333; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #e6e6e6; vertical-align: top; white-space: pre-wrap;"><div>*'''[[Novonorm]]''' 90CPR 0,5MG, 90CPR 1MG, 90CPR 2MG [http://www.ema.europa.eu/docs/it_IT/document_library/EPAR_-_Summary_for_the_public/human/000187/WC500029903.pdf''Riassunto EMA''] , [http://www.dottnet.it/TFI/Allegati.aspx?file=2007-07-005270-Novonorm%200,5mg.pdf''monografia'']</div></td></tr> <!-- diff cache key wikifarmaco_db_5-mw_:diff:version:1.11a:oldid:29533:newid:30551 --> </table>

Hadihajar https://wikifarmaco.org/index.php?title=Repaglinide&diff=29533&oldid=prev 2013-03-22T23:55:32Z

<p>‎<span dir="auto"><span class="autocomment">SPECIALITÀ</span></span></p> <table class="diff diff-contentalign-left" data-mw="interface"> <col class="diff-marker" /> <col class="diff-content" /> <col class="diff-marker" /> <col class="diff-content" /> <tr style="vertical-align: top;" lang="it"> <td colspan="2" style="background-color: white; color:black; text-align: center;">← Versione meno recente</td> <td colspan="2" style="background-color: white; color:black; text-align: center;">Versione delle 23:55, 22 mar 2013</td> </tr><tr><td colspan="2" class="diff-lineno" id="mw-diff-left-l2" >Riga 2:</td> <td colspan="2" class="diff-lineno">Riga 2:</td></tr> <tr><td class='diff-marker'>&#160;</td><td style="background-color: #f9f9f9; color: #333333; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #e6e6e6; vertical-align: top; white-space: pre-wrap;"><div>== SPECIALITÀ ==</div></td><td class='diff-marker'>&#160;</td><td style="background-color: #f9f9f9; color: #333333; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #e6e6e6; vertical-align: top; white-space: pre-wrap;"><div>== SPECIALITÀ ==</div></td></tr> <tr><td class='diff-marker'>&#160;</td><td style="background-color: #f9f9f9; color: #333333; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #e6e6e6; vertical-align: top; white-space: pre-wrap;"><div>*'''[[Novonorm]]''' 90CPR 0,5MG, 90CPR 1MG, 90CPR 2MG [http://www.ema.europa.eu/docs/it_IT/document_library/EPAR_-_Summary_for_the_public/human/000187/WC500029903.pdf''Riassunto EMA''] , [http://www.dottnet.it/TFI/Allegati.aspx?file=2007-07-005270-Novonorm%200,5mg.pdf''monografia'']</div></td><td class='diff-marker'>&#160;</td><td style="background-color: #f9f9f9; color: #333333; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #e6e6e6; vertical-align: top; white-space: pre-wrap;"><div>*'''[[Novonorm]]''' 90CPR 0,5MG, 90CPR 1MG, 90CPR 2MG [http://www.ema.europa.eu/docs/it_IT/document_library/EPAR_-_Summary_for_the_public/human/000187/WC500029903.pdf''Riassunto EMA''] , [http://www.dottnet.it/TFI/Allegati.aspx?file=2007-07-005270-Novonorm%200,5mg.pdf''monografia'']</div></td></tr> <tr><td class='diff-marker'>−</td><td style="color:black; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;"><div>*'''[[Repaglinide generico]]''' [http://www.ema.europa.eu/docs/it_IT/document_library/EPAR_-_Summary_for_the_public/human/001067/WC500053313.pdf''<del class="diffchange diffchange-inline">Riasuunto </del>EMA''] 90CPR 0,5MG, 90CPR 1MG, 90CPR 2MG</div></td><td class='diff-marker'>+</td><td style="color:black; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div>*'''[[Repaglinide generico]]''' [http://www.ema.europa.eu/docs/it_IT/document_library/EPAR_-_Summary_for_the_public/human/001067/WC500053313.pdf''<ins class="diffchange diffchange-inline">Riassunto </ins>EMA''] 90CPR 0,5MG, 90CPR 1MG, 90CPR 2MG</div></td></tr> <tr><td class='diff-marker'>&#160;</td><td style="background-color: #f9f9f9; color: #333333; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #e6e6e6; vertical-align: top; white-space: pre-wrap;"></td><td class='diff-marker'>&#160;</td><td style="background-color: #f9f9f9; color: #333333; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #e6e6e6; vertical-align: top; white-space: pre-wrap;"></td></tr> <tr><td class='diff-marker'>&#160;</td><td style="background-color: #f9f9f9; color: #333333; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #e6e6e6; vertical-align: top; white-space: pre-wrap;"><div>== STRUTTURA ==</div></td><td class='diff-marker'>&#160;</td><td style="background-color: #f9f9f9; color: #333333; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #e6e6e6; vertical-align: top; white-space: pre-wrap;"><div>== STRUTTURA ==</div></td></tr> <!-- diff cache key wikifarmaco_db_5-mw_:diff:version:1.11a:oldid:29532:newid:29533 --> </table>

Hadihajar https://wikifarmaco.org/index.php?title=Repaglinide&diff=29532&oldid=prev 2013-03-22T23:55:14Z

<p>‎<span dir="auto"><span class="autocomment">SPECIALITÀ</span></span></p> <table class="diff diff-contentalign-left" data-mw="interface"> <col class="diff-marker" /> <col class="diff-content" /> <col class="diff-marker" /> <col class="diff-content" /> <tr style="vertical-align: top;" lang="it"> <td colspan="2" style="background-color: white; color:black; text-align: center;">← Versione meno recente</td> <td colspan="2" style="background-color: white; color:black; text-align: center;">Versione delle 23:55, 22 mar 2013</td> </tr><tr><td colspan="2" class="diff-lineno" id="mw-diff-left-l2" >Riga 2:</td> <td colspan="2" class="diff-lineno">Riga 2:</td></tr> <tr><td class='diff-marker'>&#160;</td><td style="background-color: #f9f9f9; color: #333333; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #e6e6e6; vertical-align: top; white-space: pre-wrap;"><div>== SPECIALITÀ ==</div></td><td class='diff-marker'>&#160;</td><td style="background-color: #f9f9f9; color: #333333; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #e6e6e6; vertical-align: top; white-space: pre-wrap;"><div>== SPECIALITÀ ==</div></td></tr> <tr><td class='diff-marker'>&#160;</td><td style="background-color: #f9f9f9; color: #333333; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #e6e6e6; vertical-align: top; white-space: pre-wrap;"><div>*'''[[Novonorm]]''' 90CPR 0,5MG, 90CPR 1MG, 90CPR 2MG [http://www.ema.europa.eu/docs/it_IT/document_library/EPAR_-_Summary_for_the_public/human/000187/WC500029903.pdf''Riassunto EMA''] , [http://www.dottnet.it/TFI/Allegati.aspx?file=2007-07-005270-Novonorm%200,5mg.pdf''monografia'']</div></td><td class='diff-marker'>&#160;</td><td style="background-color: #f9f9f9; color: #333333; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #e6e6e6; vertical-align: top; white-space: pre-wrap;"><div>*'''[[Novonorm]]''' 90CPR 0,5MG, 90CPR 1MG, 90CPR 2MG [http://www.ema.europa.eu/docs/it_IT/document_library/EPAR_-_Summary_for_the_public/human/000187/WC500029903.pdf''Riassunto EMA''] , [http://www.dottnet.it/TFI/Allegati.aspx?file=2007-07-005270-Novonorm%200,5mg.pdf''monografia'']</div></td></tr> <tr><td class='diff-marker'>−</td><td style="color:black; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;"><div>*'''[[Repaglinide generico]]''' [http://www.ema.europa.eu/docs/it_IT/document_library/EPAR_-_Summary_for_the_public/human/001067/WC500053313.pdf''<del class="diffchange diffchange-inline">monografia</del>''] 90CPR 0,5MG, 90CPR 1MG, 90CPR 2MG</div></td><td class='diff-marker'>+</td><td style="color:black; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div>*'''[[Repaglinide generico]]''' [http://www.ema.europa.eu/docs/it_IT/document_library/EPAR_-_Summary_for_the_public/human/001067/WC500053313.pdf''<ins class="diffchange diffchange-inline">Riasuunto EMA</ins>''] 90CPR 0,5MG, 90CPR 1MG, 90CPR 2MG</div></td></tr> <tr><td class='diff-marker'>&#160;</td><td style="background-color: #f9f9f9; color: #333333; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #e6e6e6; vertical-align: top; white-space: pre-wrap;"></td><td class='diff-marker'>&#160;</td><td style="background-color: #f9f9f9; color: #333333; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #e6e6e6; vertical-align: top; white-space: pre-wrap;"></td></tr> <tr><td class='diff-marker'>&#160;</td><td style="background-color: #f9f9f9; color: #333333; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #e6e6e6; vertical-align: top; white-space: pre-wrap;"><div>== STRUTTURA ==</div></td><td class='diff-marker'>&#160;</td><td style="background-color: #f9f9f9; color: #333333; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #e6e6e6; vertical-align: top; white-space: pre-wrap;"><div>== STRUTTURA ==</div></td></tr> <!-- diff cache key wikifarmaco_db_5-mw_:diff:version:1.11a:oldid:29531:newid:29532 --> </table>

Hadihajar